All In MedTech

Device Trial Radar · NCT01437163

Treatment of Androgenetic Alopecia in Males and Females

The Growth of Human Scalp Hair Mediated By Visible Red Light Laser and LED Sources.

Last checked: Nov 20, 2026Latest source record: Jul 12, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

88

Actual

Start

Sep 2011

Primary completion

Aug 2013

Study completion Aug 2013

Sponsor

Lead sponsor
Apira Science, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Sep 20, 2011

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy of Low Level Laser and Light Therapy system configured in a novel product called the TopHat 655 system, for promoting hair growth in males and females diagnosed with androgenetic alopecia of the head.

Conditions

  • Androgenetic Alopecia

Interventions

  • TopHat 655 rejuvenation systemDevice

    TopHat 655 system is to be applied every other day for 16 weeks for a pre-programmed time period

  • Laser and/or Light Hair Rejuvenation SystemDevice

    A red incandescent light source replaces all lasers and light emitting diodes.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage Increase of Terminal Hairs from Pre-treatment, Baseline CountTime frame: After 16 weeks of therapy

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Adolfo Fernandez-Obregon, MD

    Hoboken, New Jersey

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.